In this setting, we observed that single PD-1 blockade had little effects on tumor-resident CD4+ and CD8+ T cells while slightly diminishing the levels of immunosuppressive CD4+FoxP3+ Treg and CD11b+GR-1+ MDSC in peritoneal cavity. The gene discussed is CD4; the disease is neoplasm.